The promise of deep urine proteomics for diagnosis of cancer, neurologic, and metabolic diseases

Source: Plos.org· Bogdan Budnik, Hossein Amirkhani, Klaus Weinberger, Saharnaz Nedjat, Mohammad H. Forouzanfar, Ashkan Afshin· July 30, 2026
The promise of deep urine proteomics for diagnosis of cancer, neurologic, and metabolic diseases

Introduction Urine offers a noninvasive and low-cost source of disease biomarkers, yet most proteomic studies have targeted single conditions. Using deep proteomic profiling and machine learning, we evaluated whether urinary protein signatures distinguish ear…

This story was reported by Plos.org. Read the full original article:
Read on Plos.org

More in Products & Launches

View all